Fundraising FoxColt Ventures
Crossover fundDallas · Seed–Growth · 3 people tracked
Find your way into Colt Ventures
Sign up to see every warm intro you have to Colt Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Colt Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Colt Ventures draws on decades of multi-sector investing experience, focusing on opportunities with meaningful, measurable impact. By staying targeted and narrow, the firm sources and evaluates hundreds of deals annually across private and public markets, leveraging a proprietary network of innovators, executives, and blue-chip investors. It invests up to $15M per deal, favoring inefficient markets, proven management teams, near-term value inflection points, and near-term liquidity horizons. Beyond direct private and public investments, Colt also allocates to institutional managers—hedge funds, venture capital, and private equity funds—aligned with its focus sectors and principles. The firm partners with portfolio companies to provide access to a differentiated network of industry experts.
Source: firm website, verified Sep 26, 2026.
Team · 3 people
from the firm's website
Founder and Managing Partner of Colt Ventures, a family office he established to invest his personal capital. A private investor for over 30 years, he has invested in 250+ companies across sectors including oil & gas, technology, real estate, financial services, consumer/retail, and biotechnology, and previously worked with the Esping family office and ran Able Investments.
Associate who joined Colt in 2026, leading investment analysis and diligence across the firm's oil, gas, minerals, and technology investments. Previously a family office analyst at Canterbury and began his career in wealth management at Morgan Stanley. He studied Business Administration at UC Irvine.
Associate who joined Colt in 2026, leading investment analysis, diligence, and contributing to portfolio strategy across private and public investments. Previously worked at venture-backed company Phia across product, growth, and investor-facing roles, and is an active angel investor. She studied Computer Science and Economics at UC Irvine.
What they invest in
from 1 of 8 portfolio companiesBiotech ×1Deep Tech ×1Digital Health ×1Medical Devices ×1
HQs:United States×1
Investments · 8 tracked
founders shown can be your intro path
Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Jonathan E. Lim, M.D.(Chairman, CEO and Co-founder)Gary Yeung, CFA(Chief Business Officer)in
BoardAlexander W. Casdin(Director)Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)James A. Bristol, Ph.D.(Director)
Co-investorsAndreessen HorowitzARCH Venture PartnersEvolution VC PartnersFrazier Life SciencesLifeSci Venture PartnersCity Hill Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlteromeARS PharmaBlack DiamondOdysseyProtosreataRocket
Exits · 1
1 IPOsErascaNASDAQ: ERAS
Portfolio news
latest coverage across their companiesErasca · trefis.com · Jul 4, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Erasca | 5.5% | $16.00 | Jul 2021 | $103.8M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Colt Ventures made?
- Colt Ventures has 8 tracked investments, 1 of which have exited.
- What stage does Colt Ventures invest at?
- Colt Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is Colt Ventures's typical check size?
- Colt Ventures typically writes checks of $15M.
- What sectors does Colt Ventures focus on?
- Colt Ventures focuses on Biotech, Consumer, E-commerce, Energy, Fintech, New Materials, PropTech.
- Where is Colt Ventures located?
- Colt Ventures is headquartered in Dallas, US.
- Who does Colt Ventures co-invest with?
- Colt Ventures most often shares deals with Andreessen Horowitz, ARCH Venture Partners, Evolution VC Partners, among 6 tracked co-investors.
Similar investors
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
Grazia Equity is a venture capital investor with over 25 years of VC experience, having backed technology companies through IPOs and acquisitions on NASDAQ and DAX.